United Therapeutics | UTHR - Capitaux Propres Et Réserves





Capitaux Propres Et Réserves Changement Date
Amarin USD 459.28M 387K 2025-12
Ardelyx USD 166.95M 12.67M 2025-12
Baxter International USD 6.13B 1.11B 2025-12
Bayer EUR 25.95B 3.75B 2025-12
BioCryst Pharmaceuticals USD -119.15M 268.74M 2025-12
Biogen USD 18.21B 573.5M 2025-09
BioMarin Pharmaceutical USD 6.09B 30.29M 2025-12
Emergent BioSolutions USD 649.3M 47.9M 2023-12
Esperion Therapeutics USD -301.96M 149.4M 2025-12
Gilead Sciences USD 22.62B 1.16B 2025-12
GlaxoSmithKline GBP 16.38B 229M 2025-12
Halozyme Therapeutics USD 48.81M 455.1M 2025-12
Insmed USD 738.98M 206.6M 2025-12
Ionis Pharmaceuticals USD 617.97M 13.76M 2025-09
J&J USD 78.47B 0 2025-09
Lexicon Pharmaceuticals USD 107.54M 12.62M 2025-12
Moderna USD 8.65B 680M 2025-12
Omeros USD -228.68M 15.13M 2025-06
Pfizer USD 92.8B 4.11B 2025-09
PTC Therapeutics USD -205.31M 49.56M 2025-12
Regeneron Pharmaceuticals USD 31.26B 299.1M 2025-12
Sangamo BioSciences USD 19.6M 14.7M 2025-06
Sarepta Therapeutics USD 1.14B 179.5M 2025-12
Teva Pharmaceutical Industries USD 7.91B 664M 2025-12
United Therapeutics USD 7.1B 506M 2025-12
Vertex Pharmaceuticals USD 18.67B 1.35B 2025-12